Peritonitis of the #FMF - misdiagnosed as acute abdomen Acute appendicitis is the leading cause of acute abdomen in FMF Turkish study 1655 #FMF pts 15.8% appendectomy rates! CRP ineffective for differing FMF from appendicitis :( @RheumNow #ACR22 abst#1839

Factors associated with non-achievement of MDA in PsA pts receiving golimumab: Baseline tender joint count, fibromyalgia, older age, smoking, high BMI Abs#2109 @RheumNow #ACR22 https://t.co/dEzQxVtavh

‼️‼️Frailty ‼️‼️ 👉Important predictor of serious infxn in RA pts on b- or tsDMARD irrespective of age ‼️‼️ @NamrataRheum illustrating yet another reason why it is so NB to evaluate 4 frailty in ALL (incl young) pts with RA #GeriRheum Abst2218 @RheumNow #ACR22 https://t.co/J4XQFmVoUw

While there are limitations to this study (respondents over childbearing age, white, educated, insured), within 2 months of @USSupremeCourt3's overturn of Roe v Wade, 1 in 17 MTX pts experienced a barrier to getting rx filled. ABS L09 @RheumNow #ACR22 https://t.co/WuikwO1bZ9 https://t.co/4Ve0zAVxbG

Early psoriasis and enthesitis response in PsA pts treated with guselkumab predicted longterm clinical response including MDA, DAPSA LDA, DAPSA50, DAPSA remission. Pts w/o early response, only half achieved remission Abs#2115 @RheumNow #ACR22 https://t.co/dnsQcp7cEq

BKZ showed clinically meaningful improvements in efficacy outcomes in bDMARD-naïve PsA pts at Wk 16 through wk 52. No new safety signals. ABS L02 #ACR22 @RheumNow https://t.co/Dph32O7NWG https://t.co/d7Yq3JISyF

I think this has changed my mind! Does RA benefit from changes in diet & exercise? RCT Reade @amsterdamumc n=77 mod active RA https://t.co/5Iw6hYJzGK for 16w: whole food plant-based diet/exercise/stress management 0.9 improvement in DAS28 vs placebo! ABST1998 #ACR22 @RheumNow https://t.co/u10RqmPMPd

PsA bDMARD "ranking" system by systematic literature review looked at 30 RCTs Highest probability of achieving ACR20 and PASI90: infliximab, golimumab and bimekizumab #ACRBest Abs#2123 @RheumNow #ACR22 https://t.co/KpW0p2KAQZ

🔥PrEP 4 SARS-CoV-2🔥 ➡️casirivimab/imdevimab ⚡️Detection @ D1 and stabilisation up to D30 of serum and saliva Abs in IMID pts who failed response 2 COVID vax. ❓role in preventing severe infxn in high risk pts refractory 2 vax #ACR22 @RheumNow Abst 2195 @Dr_David_Simon https://t.co/Zd00P5l363

Abstr # 1878 looked at biomarkers assoc w/ MRI muscle inflammation in #IIM - Of the potential cytokines, IL-7 strongly correlated with muscle damage on MRI thigh bilateral @RheumNow #ACR22 #Myositis https://t.co/3i3C2EGtFM